Ibrahim Halil Turkbeyler Selected Research

1- (2- (4- benzyl- 4- hydroxypiperidin- 1- yl)ethyl)- 3- (2- methylquinolin- 4- yl)urea

8/2014	Palosuran treatment effective as bosentan in the treatment model of pulmonary arterial hypertension.
4/2013	Urotensin inhibition with palosuran could be a promising alternative in pulmonary arterial hypertension.
6/2012	The efficiency of a urotensin II antagonist in an experimental lung fibrosis model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ibrahim Halil Turkbeyler Research Topics

Disease

3	Pulmonary Arterial Hypertension 08/2014 - 05/2012
3	Systemic Scleroderma (Systemic Sclerosis) 04/2013 - 05/2012
1	Ulcer 01/2014
1	Fibrosis (Cirrhosis) 06/2012
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 05/2012
1	Adenocarcinoma of Lung 05/2012
1	Lung Neoplasms (Lung Cancer) 05/2012
1	Pancytopenia 01/2011
1	Thrombocytopenia (Thrombopenia) 01/2011
1	Glioblastoma (Glioblastoma Multiforme) 01/2011
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 01/2011

Drug/Important Bio-Agent (IBA)

3	1- (2- (4- benzyl- 4- hydroxypiperidin- 1- yl)ethyl)- 3- (2- methylquinolin- 4- yl)ureaIBA 08/2014 - 06/2012
2	urotensin IIIBA 04/2013 - 06/2012
1	Bosentan (Tracleer)FDA Link 08/2014
1	Cetuximab (Erbitux)FDA Link 01/2014
1	UrotensinsIBA 04/2013
1	AdipokinesIBA 08/2012
1	CollagenIBA 08/2012
1	LeptinIBA 08/2012
1	ResistinIBA 08/2012
1	Endothelin-1 (Endothelin 1)IBA 06/2012
1	Bleomycin (Blenoxane)FDA LinkGeneric 06/2012
1	Iloprost (Ventavis)FDA Link 05/2012
1	Temozolomide (Temodar)FDA LinkGeneric 01/2011
1	Alkylating AgentsIBA 01/2011

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2011